GLP-1 Lawsuit Guides & Articles
Plain-English explainers about Ozempic, Wegovy, Mounjaro, and the federal GLP-1 litigation. General information only — not legal advice.
- March 1, 2026 · 6 min read
How to Document a GLP-1 Injury for a Claim
Cases live and die on records. Here is the practical checklist of what to collect before — or right after — requesting a case review.
Read article → - February 22, 2026 · 6 min read
Ozempic vs Wegovy vs Mounjaro
Three drugs, two molecules, one mass tort. Here is what actually distinguishes them — and why all three sit inside the same federal litigation.
Read article → - February 15, 2026 · 7 min read
What to Expect from a Mass Tort Settlement
Mass tort settlements rarely look like the headlines. Here is a realistic walkthrough of timing, valuation, fees, and what actually ends up in your pocket.
Read article → - February 8, 2026 · 8 min read
GLP-1 Side Effects: The Full Spectrum
Most patients tolerate Ozempic and similar drugs fine. A meaningful minority don't. Here is the full spectrum of GLP-1 side effects, from minor to litigation-worthy.
Read article → - February 1, 2026 · 5 min read
Do I Have an Ozempic Case?
Five questions — answer yes to most of them and you should request a free case review. Nothing here is legal advice.
Read article → - January 25, 2026 · 6 min read
Statute of Limitations for GLP-1 Lawsuits, by State
Every state limits how long you have to file. Here is a general overview for the most common states, and why "the discovery rule" matters for GLP-1 cases.
Read article → - January 20, 2026 · 8 min read
How MDL 3094 (Federal GLP-1 Litigation) Works
MDL 3094 is the consolidated federal litigation for GLP-1 drug injuries. Here is what "MDL" means, how it differs from a class action, and what to expect.
Read article → - January 15, 2026 · 7 min read
What Is Gastroparesis?
Gastroparesis means your stomach empties much more slowly than normal. Here is what causes it, how it's diagnosed, and why it keeps showing up in GLP-1 lawsuits.
Read article →